Repair the Lining. Quiet the Inflammation. Restore the Ecosystem.
A physician-designed programme that addresses why your gut barrier is compromised, not just the downstream symptoms. BPC-157 and Thymosin Alpha-1 as the peptide core, NAD+ microdosing for enterocyte support, KPV layered in when inflammation is active, plus microbiome rebuilding and the lifestyle layer. For adults whose gut has not been right despite diets, probiotics and GI visits.
Doctor-led. Diagnostically gated. Pune and Mumbai.
Personalised programme. Comprehensive longevity workup. Long-arc cadence.
Outcomes vary. ALIV does not guarantee biological age reversal, lifespan extension or disease prevention.
Repair the Lining. Quiet the Inflammation. Restore the Ecosystem.
A physician-designed programme that addresses why your gut barrier is compromised, not just the downstream symptoms. BPC-157 and Thymosin Alpha-1 as the peptide core, NAD+ microdosing for enterocyte support, KPV layered in when inflammation is active, plus microbiome rebuilding and the lifestyle layer. For adults whose gut has not been right despite diets, probiotics and GI visits.
Doctor-led. Diagnostically gated. Pune and Mumbai.
Personalised programme. Comprehensive longevity workup. Long-arc cadence.
Outcomes vary. ALIV does not guarantee biological age reversal, lifespan extension or disease prevention.
The intestinal lining is a single-cell-thick barrier held together by tight junctions, with mucus, immune cells and a microbial community on top. When NSAIDs, antibiotics, chronic stress, infection or inflammatory triggers damage this barrier, increased permeability triggers immune activation and chronic low-grade inflammation.
BPC-157, originally isolated from human gastric juice (gut-native, stable in gastric acid), stabilises tight junctions, accelerates mucosal healing and counteracts NSAID-induced damage. Thymosin Alpha-1 re-balances the immune dysregulation that underlies most chronic gut dysfunction.
Enterocytes turn over every 3 to 5 days and depend on mitochondrial function. Microdosed NAD+ supports enterocyte energy via the SIRT1 pathway, preserving tight junction integrity.
KPV is taken up by intestinal epithelial cells via the PepT1 transporter (upregulated in inflamed tissue), where it inhibits NF-κB signalling. Targeted anti-inflammatory effect.
Targeted probiotic strains, prebiotic fibres where tolerated, dietary diversity that rebuilds microbial richness over time.
Detailed history, inflammatory markers, micronutrient status, food-related antibodies where indicated, stool testing where appropriate, plus red-flag screening for gastroenterology referral.
Peptides accelerate repair. The gut barrier is rebuilt, or continues to break down, by what you do every day.
Q. Is "leaky gut" a real medical condition?
A. Intestinal permeability is real and measurable, a recognised factor in IBD, food sensitivities and several autoimmune conditions. The lay term "leaky gut" describes this imprecisely, but the underlying biology is legitimate.
Q. How do I heal a leaky gut?
A. Four parallel layers: remove ongoing injury (NSAIDs, unnecessary antibiotics, alcohol, chronic stress); supply substrate (protein, glutamine, zinc, vitamin A, omega-3, polyphenols); accelerate epithelial repair (BPC-157, Tα1, NAD+ microdosing, KPV when inflammation is high); rebuild the microbial ecosystem.
Q. Can IBS be cured?
A. Depends on cause. IBS is a heterogeneous label. Many functional cases respond substantially to addressing the actual driver; some symptoms become manageable rather than fully resolved.
Q. How is this different from probiotics?
A. Probiotics address microbiome composition but do not directly repair a damaged gut barrier. This protocol combines targeted barrier repair with microbiome work designed for your specific picture.
Q. Who should not do this protocol?
A. Active serious illness or undiagnosed symptoms requiring specialist evaluation first; active bowel obstruction or other acute surgical conditions; untreated significant infection; pregnancy or breastfeeding; clients seeking to bypass appropriate gastroenterology workup.
Most gut treatment in India is symptom management. ALIV's Gut Barrier Protocol identifies what is actually compromising your gut barrier and addresses it: peptide-led repair, microbiome rebuilding and lifestyle drivers. Doctor-led, GI-aware, Pune and Mumbai.
Peptide core (BPC-157, Thymosin Alpha-1), NAD+ microdosing for enterocyte energy, KPV when inflammation is elevated, microbiome-aware rebuilding, and a diagnostic backbone including red-flag screening.
Generic probiotic-and-fibre advice rarely fixes a damaged barrier. The protocol works in four parallel directions: remove ongoing injury, supply substrate, accelerate epithelial repair, rebuild the microbial ecosystem.
Adults with chronic bloating, IBS-pattern symptoms, expanding food sensitivities, post-antibiotic or post-COVID gut changes, NSAID-damaged lining, or gut-driven skin, joint and fatigue symptoms.
Doctor-led, diagnostically gated, integrative with gastroenterology specialists where indicated.
How quickly will I notice less bloating?
Many clients describe shifts within 2 to 6 weeks. Wider food tolerance and downstream improvement build over months.
Will I need stool testing?
Sometimes, where indicated by symptom pattern.
Can I do this if I am on a biologic for IBD?
Possibly, under careful coordination with your gastroenterologist.
Will I have to be on peptides forever?
No. Initial phase is 3 to 6 months. Maintenance reviewed quarterly.
Are these peptides safe?
Used under physician supervision with informed consent. Tα1 has the strongest human evidence base of the three.